These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2536789)

  • 1. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
    Lanata CF; Black RE; del Aguila R; Gil A; Verastegui H; Gerna G; Flores J; Kapikian AZ; Andre FE
    J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
    Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea.
    Linhares AC; Lanata CF; Hausdorff WP; Gabbay YB; Black RE
    Pediatr Infect Dis J; 1999 Nov; 18(11):1001-6. PubMed ID: 10571438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
    Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G
    Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants.
    Treanor JJ; Clark HF; Pichichero M; Christy C; Gouvea V; Shrager D; Palazzo S; Offit P
    Pediatr Infect Dis J; 1995 Apr; 14(4):301-7. PubMed ID: 7603812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.
    Vesikari T; Ruuska T; Delem A; André FE; Beards GM; Flewett TH
    Acta Paediatr Scand; 1991 Feb; 80(2):173-80. PubMed ID: 1852084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The present status of rotavirus vaccine development.
    Bishop R
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):429-35. PubMed ID: 2851184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.
    Clark HF; Borian FE; Bell LM; Modesto K; Gouvea V; Plotkin SA
    J Infect Dis; 1988 Sep; 158(3):570-87. PubMed ID: 2842405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.
    Clark HF; Borian FE; Plotkin SA
    J Infect Dis; 1990 Jun; 161(6):1099-104. PubMed ID: 2161038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
    Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
    N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First rotavirus vaccine licensed: is there really a need?
    Glass RI; Bresee JS; Parashar UD; Holman RC; Gentsch JR
    Acta Paediatr Suppl; 1999 Jan; 88(426):2-8. PubMed ID: 10088904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
    Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
    Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
    Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
    J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.
    Bernstein DI; Smith VE; Sander DS; Pax KA; Schiff GM; Ward RL
    J Infect Dis; 1990 Nov; 162(5):1055-62. PubMed ID: 2172394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic.
    Vesikari T; Isolauri E; Delem A; d'Hondt E; André FE; Beards GM; Flewett TH
    J Pediatr; 1985 Aug; 107(2):189-94. PubMed ID: 3894608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates.
    Dagan R; Kassis I; Sarov B; Midthun K; Davidson BL; Vesikari T; Sarov I
    Pediatr Infect Dis J; 1992 Dec; 11(12):991-6. PubMed ID: 1334255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.